OPERATIONS

Michaels CFO Resigns

BY CSA STAFF

Irving, Texas Michaels Stores announced that Jeffrey Boyer, president and CFO, will resign effective April 4.

Michaels will conduct a search for a replacement CFO and will consider both internal and external candidates, the company said.

In the interim, the company has named Lisa K. Klinger, senior VP of finance and treasurer, to be acting CFO.

It has also named Richard S. Jablonski, VP of finance and corporate controller, to serve as principal accounting officer.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

Polls

Consumer confidence is high. Is that reflected in your stores’ revenues?

View Results

Loading ... Loading ...
News

Staples makes offer to buy Corporate Express

BY CSA STAFF

FRAMINGHAM, Mass. Staples today confirmed that it will make a public offer for all the outstanding ordinary shares and American depositary shares issued by Corporate Express for a price of EUR 7.25 ($8.63) per ordinary share and ADS.

“While we continue to be disappointed that Corporate Express’ Executive and Supervisory Boards have not entered into a negotiation with us about the transaction, we remain very enthusiastic about a combination between the two companies,” said Ron Sargent, Staples chairman and ceo. “Based on public information, Staples firmly believes its proposal is the most valuable option available to Corporate Express’ shareholders and will deliver significant benefits for customers and employees.”

Staples expects to submit a request for approval of the offer memorandum in respect of the offer to the Netherlands Authority for the Financial Markets before May 13, which is the date by which under Dutch law a request for approval must be submitted to the AFM. In addition, Staples plans to make all necessary competition regulatory filings prior to May 13.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

Polls

Consumer confidence is high. Is that reflected in your stores’ revenues?

View Results

Loading ... Loading ...
News

CVS settles ranitidine dispension suit

BY CSA STAFF

WOONSOCKET, R.I. CVS Caremark today said that it has reached a settlement agreement with the U.S. Department of Justice and a number of state Attorneys General to resolve an investigation into the practice of its CVS/pharmacy retail pharmacies of dispensing the generic drug ranitidine in capsule rather than tablet form to Medicaid recipients.

CVS Caremark has denied any wrongful conduct and said that that for many years it has dispensed the capsule from of rantidine to all patients, not just Medicaid recipients, due to the fact that the acquisition cost of capsules was lower than the cost of tablets. According to the company, both forms contain the same active ingredients.

According to CVS Caremark, the government alleged that the practice of dispensing capsules instead of tablets was motivated by a desire to increase Medicaid reimbursement. The company has expressly denied this allegation.

The settlement calls for payment by the company of $36.7 million, plus approximately $800,000 in investigative costs and other fees. The company said this will not affect its 2008 earnings results.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

Polls

Consumer confidence is high. Is that reflected in your stores’ revenues?

View Results

Loading ... Loading ...